Christopher J Vodila, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 314 Basin St Sw, Ephrata, WA 98823 Phone: 509-663-8711 |
Jo Prophet, ARNP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 314 Basin St Sw, Ephrata, WA 98823 Phone: 509-663-8711 |
Miss Lisa Kristine Corsie, A.R.N.P. Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 220 Nat Washington Way, Ephrata, WA 98823 Phone: 509-754-3330 Fax: 509-754-2351 |
Meagan Ann Caldwell, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 200 Nat Washington Way, Ephrata, WA 98823 Phone: 509-754-3330 |
Steven J Stokes, ARNP Nurse Practitioner - Psych/Mental Health Medicare: Medicare Enrolled Practice Location: 68 L St Ne, Ephrata, WA 98823 Phone: 509-753-3151 |
Nadine Strand Mahler, ARNP Nurse Practitioner - Gerontology Medicare: Not Enrolled in Medicare Practice Location: 220 Nat Washington Way, Ephrata, WA 98823 Phone: 509-754-3330 Fax: 509-754-4809 |
Deanna S Snyder, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 200 Nat Washington Way, Ephrata, WA 98823 Phone: 509-754-3330 Fax: 509-754-6356 |
News Archive
Mice genetically deficient in serotonin - a crucial brain chemical implicated in clinical depression - are more vulnerable than their normal littermates to social stressors, according to a Duke study appearing this week in the Proceedings of the National Academy of Sciences.
A species of gut bacteria called Clostridium ramosum, coupled with a high-fat diet, may cause animals to gain weight. The work is published this week in mBio-, the online open-access journal of the American Society for Microbiology.
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today presented positive results from the LATTE-2 study at the Conference on Retroviruses and Opportunistic Infections (CROI) in Boston. Headline results were announced in November 2015.
FibroGen, Inc., today announced that FG-3019, the Company's human monoclonal antibody against connective tissue growth factor (CTGF), has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for the treatment of idiopathic pulmonary fibrosis (IPF).
Thus, this team of scientists have determined a seasonal risk threshold among patients with folate deficiency, since, according to this study, folate levels decrease significantly in those months when solar radiation is higher.
› Verified 7 days ago